AbbVie Inc (NYSE:ABBV), a pharmaceuticals company, has released its earnings report for Q1 2015.

AbbVie reported earnings per share of 94 cents for the first quarter of 2015. This is up roughly 32% from its earnings per share that it reported during the same time last year. It also beat out analysts’ earnings per share estimates of 85 cents for its first quarter of 2015.

Revenue reported by AbbVie for Q1 2015 came in at $5.04 billion. This is almost an 18% increase from Q1 2014. It also beat out an estimated revenue for the quarter of $4.98 billion from analysts. The company’s increased revenue was due in part to Humira sales, which were up 18% to $3.1 million.

In its Q1 2015 earnings report, AbbVie raised its guidance for 2015. The company is expecting earnings per share between $4.10 to $4.30 for the current year. Its previous guidance for 2015 had earnings per share sitting between $4.05 to $4.25.

More From InvestorPlace